REGENXBIO Ownership | Who Owns REGENXBIO?


OverviewForecastRevenueFinancialsChartTranscripts

REGENXBIO Ownership Summary


REGENXBIO is owned by 81.12% institutional investors, 7.59% insiders, and 11.29% retail investors. Blackrock is the largest institutional shareholder, holding 18.83% of RGNX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.94% of its assets in REGENXBIO shares.

RGNX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockREGENXBIO81.12%7.59%11.29%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.61M18.83%$100.73M
Blackrock funding, inc. /de5.47M10.76%$42.25M
Redmile group4.79M9.44%$37.06M
Jpmorgan chase4.14M8.14%$31.98M
State street2.87M6.28%$33.62M
Vanguard group2.99M5.88%$23.08M
Millennium management1.32M2.60%$10.22M
Morgan stanley1.18M2.58%$13.80M
Balyasny asset management1.19M2.34%$9.18M
Dimensional fund advisors lp1.17M2.31%$9.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp453.08K10.94%$5.30M
Aquilo capital management346.30K4.04%$2.68M
Redmile group4.79M2.58%$37.06M
Lion point capital, lp57.75K2.34%$446.41K
Integral health asset management950.00K1.06%$11.12M
Ghost tree capital170.00K0.62%$1.99M
Archpoint investors221.53K0.56%$1.71M
Napatree capital49.76K0.47%$582.24K
Avidity partners management lp532.00K0.40%$4.11M
Adar1 capital management170.13K0.26%$1.32M

Top Buyers

HolderShares% AssetsChange
Jpmorgan chase4.14M0.00%1.66M
Millennium management1.32M0.01%1.06M
Blackrock8.61M0.00%1.01M
Norges bank449.40K0.00%449.40K
Cubist systematic strategies361.31K0.02%361.31K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de5.47M0.00%-3.38M
Vanguard group2.99M0.00%-1.38M
Avidity partners management lp532.00K0.40%-600.56K
Aquilo capital management346.30K4.04%-584.41K
Adage capital partners gp---500.00K

New Positions

HolderShares% AssetsChangeValue
Norges bank449.40K0.00%449.40K$3.47M
Voss capital332.81K0.19%332.81K$2.57M
Renaissance271.30K0.00%271.30K$2.10M
Raymond james financial73.51K0.00%73.51K$568.23K
Point72 asia (singapore) pte.57.84K0.12%57.84K$447.11K

Sold Out

HolderChange
Tradewinds capital management-3.00
Mendota financial group-4.00
Smartleaf asset management-5.00
Nelson, van denburg & campbell wealth management group-8.00
Innealta capital-8.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025171-6.04%41,665,554-0.97%811.18%87-9.38%548.00%
Dec 31, 2024170-11.92%38,152,884-12.63%751.02%92-3.16%46-9.80%
Sep 30, 20241934.32%43,669,664-0.24%851.15%96-4.95%5110.87%
Jun 30, 2024181-5.73%43,737,0103.28%951.02%100-1.96%44-15.38%
Mar 31, 202419210.34%42,349,93811.14%961.29%10225.93%52-11.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.94M5.94%-
JPMorgan Small Cap Growth A1.98M3.94%-
Vanguard US Total Market Shares ETF1.40M2.80%-
Vanguard Total Stock Mkt Idx Inv1.40M2.79%-
iShares Russell 2000 ETF1.19M2.37%582.00
SPDR® S&P Biotech ETF996.50K2.01%-6.06K
Vanguard Institutional Extnd Mkt Idx Tr713.85K1.42%1.86K
Vanguard Strategic Small-Cap Equity Inv632.38K1.26%347.06K
Vanguard Small Cap Index561.89K1.13%3.30K
Fidelity Small Cap Index461.42K0.92%2.16K

Recent Insider Transactions


DateNameRoleActivityValue
May 12, 2025Mills Kenneth T.-Sell$163.05K
Oct 01, 2024KARABELAS ARGERIS N-Sell$101.05K
Sep 03, 2024KARABELAS ARGERIS N-Sell$106.95K
Sep 03, 2024KARABELAS ARGERIS N-Sell$8.64K
Aug 01, 2024KARABELAS ARGERIS N-Sell$129.12K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1--
2024 Q4-1
2024 Q3-13
2024 Q2-2

RGNX Ownership FAQ


Who Owns REGENXBIO?

REGENXBIO shareholders are primarily institutional investors at 81.12%, followed by 7.59% insiders and 11.29% retail investors. The average institutional ownership in REGENXBIO's industry, Biotech Stocks , is 63.96%, which REGENXBIO exceeds.

Who owns the most shares of REGENXBIO?

REGENXBIO’s largest shareholders are Blackrock (8.61M shares, 18.83%), Blackrock funding, inc. /de (5.47M shares, 10.76%), and Redmile group (4.79M shares, 9.44%). Together, they hold 39.02% of REGENXBIO’s total shares outstanding.

Does Blackrock own REGENXBIO?

Yes, BlackRock owns 18.83% of REGENXBIO, totaling 8.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 100.73M$. In the last quarter, BlackRock increased its holdings by 1.01M shares, a 13.29% change.

Who is REGENXBIO’s biggest shareholder by percentage of total assets invested?

Sonic gp is REGENXBIO’s biggest shareholder by percentage of total assets invested, with 10.94% of its assets in 453.08K REGENXBIO shares, valued at 5.3M$.

Who is the top mutual fund holder of REGENXBIO shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of REGENXBIO shares, with 5.94% of its total shares outstanding invested in 2.94M REGENXBIO shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools